• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Edwards Lifesciences Corp. (EW)

    -NYSE
    129.90 Down 0.85(0.65%) Dec 26, 4:07PM EST
    Add to Portfolio
    Prev Close:130.75
    Open:130.93
    Bid:129.24 x 400
    Ask:133.31 x 100
    1y Target Est:139.32
    Beta:0.46
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:129.56 - 131.24
    52wk Range:63.04 - 134.29
    Volume:256,715
    Avg Vol (3m):943,138
    Market Cap:13.90B
    P/E (ttm):18.16
    EPS (ttm):7.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    EWDown 0.65%13.90B
    ICUIDown 0.08%1.28B
    MDTDown 0.63%72.46B
    STJDown 0.30%19.00B

    Key Statistics

    Forward P/E (1 yr):32.23
    P/S (ttm):6.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.39
    Quarterly EPS Est (Dec-14) :0.95
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.59

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback